市場調查報告書
商品編碼
1351032
全球骨科植入物市場 2023-2030Global Orthopedic Implants Market 2023-2030 |
預計全球骨科植入物市場在預測期內將以 5.0% 的年複合成長率成長。市場的成長歸因於人口老化加劇、骨科疾病盛行率上升、醫療技術進步以及骨科手術數量不斷增加等因素。此外,對更好生活品質的需求和微創外科手術的採用是預計推動骨科植入物需求的一些因素。此外,運動傷害是骨科植入物需求的重要驅動力,導致植入物技術的進步和微創手術的發展。關節置換術,尤其是膝關節和髖關節置換術,是受運動傷害影響的常見手術。新興市場對植入物的接受度不斷提高、醫療保健支出增加以及體育文化的擴張進一步促進了骨科植入物市場的成長。
全球骨科植入物市場根據產品類型、生物材料和類型進行細分。根據產品類型,市場分為重建關節置換、脊椎植入物、牙科植入物、創傷、骨科生物製劑等。根據生物材料,市場分為金屬生物材料、陶瓷生物材料、聚合物生物材料等。此外,根據類型,市場分為膝蓋、髖部、腕部和肩部、牙科、脊椎等。在這些細分市場中,重建關節置換預計將佔據顯著的市場佔有率。
在產品類型細分市場中,脊椎植入物子細分市場預計將在預測期內顯著成長。此細分市場的成長主要歸因於人口老化以及脊椎疾病和損傷日益流行等因素。根據聯合脊椎協會的數據,每年約有 17,700 名美國人遭受脊髓損傷。大約 78% 是男性,平均年齡為 43 歲。大多數脊髓損傷是由於車禍 (39.3%) 造成的,其次是跌倒 (31.8%),其次是暴力 (13.2%)、運動 (8 %)和醫療/外科手術(4.3%)。市場也受到研發以及新產品和解決方案的推出等因素的影響。提供脊椎骨科產品的一些主要參與者包括 Medtronic、DePuy Synthes、Stryker Corp.、Zimmer Biomet 和 Globus Medical 等。
全球骨科植入物市場根據地理位置進一步細分,包括北美(美國和加拿大)、歐洲(義大利、西班牙、德國、法國等)、亞太地區(印度、中國、日本、韓國和其他)以及世界其他地區(中東、非洲和拉丁美洲)。可根據要求對特定地區或國家層級的市場進行分析。其中,歐洲市場預計將在預測期內實現顯著成長。然而,預計亞太地區骨科植入物市場將大幅成長。
在這些地區中,預計北美地區在預測期內將在骨科植入物市場中佔據重要佔有率。該地區骨科植入物市場的成長主要受到骨科疾病高盛行率、完善的醫療基礎設施以及先進骨科植入物的日益採用等因素的推動。例如,2022 年 8 月,OSSIO, Inc. 在美國推出並商業使用 OSSIO Fiber (R) 縫合錨,這是一種比皮質骨更堅固的獨特植入材料,用於將縫合線固定到骨骼上。該材料允許骨骼快速生長和整合,而不會產生不良的生物反應,可用於各種外科手術。
服務全球骨科植入物市場的主要公司包括:印度 Medtronic Pvt. Ltd.、Medical Devices Business Services, Inc.、Smith & Nephew plc、Stryker 和 Zimmer Biomet 等。市場參與者透過各種策略(包括併購、合作、合作、融資和新產品發布),為市場成長做出巨大貢獻,以維持市場競爭力。例如,2022 年 2 月,全錄輝宣佈在日本推出 CORI 手術系統。這種新一代機器人系統專為骨科市場的機器人輔助手術而設計。此次推出之際,日本對機器人輔助手術的需求預計將大幅成長。 CORI 手術系統擴展了 Smith + Nephew 機器人平台的功能,包括全髖關節置換術。該系統於 2020 年獲得 FDA 批准,是 NAVIO 平台的繼任者。
Title: Global Orthopedic Implants Market Size, Share & Trends Analysis Report by Product Type (Reconstructive Joint Replacements, Spinal Implants, Dental Implants, Trauma, Orthobiologics, and Others), by Biomaterial (Metallic Biomaterials, Ceramic Biomaterials, Polymeric Biomaterials, and Others), and by Type (Knee, Hip, Wrist and Shoulder, Dental, Spine, and Others)Forecast Period (2023-2030).
The global orthopedic implants market is anticipated to grow at a considerable CAGR of 5.0% during the forecast period. The growth of the market is attributed to factors such as an increasing aging population, rising prevalence of orthopedic conditions, advancements in medical technologies, and a growing number of orthopedic surgeries. Further, the demand for better quality of life and the adoption of minimally invasive surgical procedures are some of the factors anticipated to fuel the demand for Orthopedic Implants. Moreover, sports injuries are a significant driver of demand for orthopedic implants, leading to advancements in implant technology and the development of minimally invasive procedures. Joint replacements, especially knee and hip replacements, are common procedures influenced by sports injuries. The growing acceptance of implants, increased healthcare spending, and expanding sports culture in emerging markets further enhance the orthopedic implant market's growth.
The global orthopedic implants market is segmented based on its Product Type, Biomaterial, and Type. Based on its Product Type, the market is segmented into Reconstructive Joint Replacements, Spinal Implants, Dental Implants, Trauma, Orthobiologics, and Others. Based on Biomaterial, the market is categorized into Metallic Biomaterials, Ceramic Biomaterials, Polymeric Biomaterials, and Others. Further, based on Type, the market is segmented into Knee, Hip, Wrist and Shoulder, Dental, Spine, and Others. Among the segments, Reconstructive Joint Replacements are anticipated to hold a prominent market share.
Among the product type segment, the spinal implants sub-segment is anticipated to register significant growth for the forecast period. The growth of the segment is primarily attributed to factors such as an aging population and the increasing prevalence of spinal disorders and injuries. According to the United Spinal Association, approximately 17,700 Americans acquire a spinal cord injury every year. Roughly 78% are men, and their average age is 43. Most spinal cord injuries happen as a result of a vehicle accident (39.3%), followed closely by falls (31.8%), trailed by violence (13.2%), sports (8%), and medical/surgical procedures (4.3%). The market is also influenced by factors such as research and development and the launches of new products and solutions. Some of the key players offering spine orthopedic products include Medtronic, DePuy Synthes, Stryker Corp., Zimmer Biomet, and Globus Medical, among others.
The global Orthopedic Implants market is further segmented based on geography, including North America (the US and Canada), Europe (Italy, Spain, Germany, France, and Others), Asia-Pacific (India, China, Japan, South Korea, and Others), and the Rest of the World (the Middle East & Africa and Latin America). The market can be analyzed for a particular region or country level as per the requirement. Among these, the Europe market is anticipated to cater to prominent growth over the forecast period. However, the Asia-Pacific region is projected to experience considerable growth in the Orthopedic Implants market.
Among these regions, the North America region is anticipated to account for a significant share in the Orthopedic Implants market during the forecast period. The growth of the Orthopedic Implants market in the region is primarily driven by factors such as a high prevalence of orthopedic disorders, well-established healthcare infrastructure, and increasing adoption of advanced orthopedic implants. For instance, in August 2022, OSSIO, Inc. launched and commercially used OSSIOfiber® Suture Anchors in the US, a unique implant material stronger than cortical bone for fixation of suture to bone. The material allows for rapid bone in-growth and integration without adverse biological response, with various surgical applications available.
The major companies serving the global orthopedic implants market include: India Medtronic Pvt. Ltd., Medical Devices Business Services, Inc., Smith & Nephew plc, Stryker, and Zimmer Biomet, among others. The market players are considerably contributing to the market growth by adopting various strategies, including mergers and acquisitions, partnerships, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in February 2022, Smith+Nephew announced the launch of its CORI Surgical System in Japan. This next-generation robotics system is designed for robotic-assisted surgery in the orthopedic market. The launch comes at a time when the demand for robotic-assisted surgery in Japan is expected to grow significantly. The CORI Surgical System expands the capabilities of Smith+Nephew's robotics platform and includes total hip arthroplasty. The system was approved by the FDA in 2020 and is the successor to the NAVIO platform.